A phase II single-arm study of pazopanib and paclitaxel as first-line treatment for patients with advanced melanoma

被引：2
|
作者：
Fruehauf, John P.
Alger, Beverly
Jakowatz, James G.
Hsiang, David
Sender, Leonard S.
Bettis, Claudette
Casey, Cameron
机构：
[1] UCI Comprehens Canc Ctr, Orange, CA USA
[2] Univ Calif Irvine, Orange, CA 92668 USA
[3] Univ Calif Irvine, Med Ctr, Orange, CA USA
[4] UC Irvine Med Ctr, Orange, CA USA
[5] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Orange, CA 92668 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.9036
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9036
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A Single-Arm Phase II Trial of First-Line Paclitaxel in Combination with Lapatinib in HER2-Overexpressing Metastatic Breast Cancer
    Jagiello-Gruszfeld, Agnieszka
    Tjulandin, Sergei
    Dobrovolskaya, Natalya
    Manikhas, Alexey
    Pienkowski, Tadeusz
    DeSilvio, Michelle
    Ridderheim, Mona
    Abbey, Rowena
    ONCOLOGY, 2010, 79 (1-2) : 129 - 135
  • [32] Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma
    McDermott, David F.
    Lee, Jae-Lyun
    Bjarnason, Georg A.
    Larkin, James M. G.
    Gafanov, Rustem A.
    Kochenderfer, Mark D.
    Jensen, Niels Viggo
    Donskov, Frede
    Malik, Jahangeer
    Poprach, Alexandr
    Tykodi, Scott S.
    Alonso-Gordoa, Teresa
    Cho, Daniel C.
    Geertsen, Poul F.
    Climent Duran, Miguel Angel
    DiSimone, Christopher
    Silverman, Rachel Kloss
    Perini, Rodolfo F.
    Schloss, Charles
    Atkins, Michael B.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (09) : 1020 - 1028
  • [33] Study protocol for an open-label, single-arm, phase Ib/II study of combination of toripalimab, nab-paclitaxel, and gemcitabine as the first-line treatment for patients with unresectable pancreatic ductal adenocarcinoma
    Shui, Lin
    Cheng, Ke
    Li, Xiaofen
    Shui, Pixian
    Zhou, Xiaohan
    Li, Jian
    Yi, Cheng
    Cao, Dan
    BMC CANCER, 2020, 20 (01)
  • [34] Study protocol for an open-label, single-arm, phase Ib/II study of combination of toripalimab, nab-paclitaxel, and gemcitabine as the first-line treatment for patients with unresectable pancreatic ductal adenocarcinoma
    Lin Shui
    Ke Cheng
    Xiaofen Li
    Pixian Shui
    Xiaohan Zhou
    Jian Li
    Cheng Yi
    Dan Cao
    BMC Cancer, 20
  • [35] A multicenter, single-arm, open-label phase II study to evaluate the efficacy and safety of YH003 in combination with pembrolizumab and nab-paclitaxel in the first-line treatment of patients with unresectable/metastatic mucosal melanoma
    Chen, Yu
    Zhang, Xiaoshi
    Ding, Ya
    Jiang, Yu
    Chen, Jing
    Pu, Xingxiang
    Ren, Xiubao
    Zhang, Weizhen
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [36] A phase II, open-label, single-arm study of QL1604 plus paclitaxel-cisplatin/carboplatin as first-line treatment in patients with recurrent or metastatic cervical cancer
    Liu, J.
    Fang, C.
    Zhou, Q.
    He, L.
    Yu, J.
    Li, Y.
    Feng, M.
    Pan, M.
    Zhao, L.
    Tang, D.
    Li, X.
    Tan, B.
    An, R.
    Zheng, X.
    Si, M.
    Zhang, B.
    Li, L.
    Kang, X.
    ANNALS OF ONCOLOGY, 2022, 33 : S1506 - S1506
  • [37] Update results of paclitaxel and cisplatin in combination with anlotinib as first-line regimen for patients with advanced ESCC: A multicenter, single-arm, open-label phase II clinical trial.
    Wang, Junsheng
    Wu, Tao
    Luo, Suxia
    Li, Ning
    Hong, Yonggui
    Guo, Yanzhen
    Cheng, Yufeng
    Li, Baosheng
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [38] A prospective single arm phase II study of dacarbazine and treosulfan as first-line therapy in metastatic uveal melanoma
    O'Neill, Penny A.
    Butt, Mohammad
    Eswar, Chinnamani V.
    Gillis, Pat
    Marshall, Ernest
    MELANOMA RESEARCH, 2006, 16 (03) : 245 - 248
  • [39] Sintilimab combined sorafenib as first-line therapy in patients with advanced hepatocellular carcinoma: A single-arm, single-center, open-label, phase II study.
    Wang, Jiabei
    Liu, Lianxin
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16182 - E16182
  • [40] Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study
    O'Day, S. J.
    Maio, M.
    Chiarion-Sileni, V.
    Gajewski, T. F.
    Pehamberger, H.
    Bondarenko, I. N.
    Queirolo, P.
    Lundgren, L.
    Mikhailov, S.
    Roman, L.
    Verschraegen, C.
    Humphrey, R.
    Ibrahim, R.
    de Pril, V.
    Hoos, A.
    Wolchok, J. D.
    ANNALS OF ONCOLOGY, 2010, 21 (08) : 1712 - 1717
12345